Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Large-Scale Data Analysis of Post-Traumatic Stress Disorder (PTSD) Through GWAS Fine-Mapping and Systems Biology.
Journal: Journal of personalized medicine
Published: February 16, 2026
Correction: Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia.
Journal: Frontiers in public health
Published: October 31, 2025
Multi-Locus Pro-Dopaminergic Restoration of Reward Brain Circuitry in Reward Deficiency Rescinds Mono-Pharmaceutical Targeting.
Journal: Neurology (E-Cronicon)
Published: September 29, 2025
Dopaminergic Homeostatic Therapy (DHT™) as a Putative Anti-Addiction Seeking Intervention and Early Identification of Genetic Preaddiction with Genetic Addiction Risk Severity (GARS®) Screening.
Journal: Acta scientific neurology
Published: September 02, 2025
Beyond Stigma-Integrating Neurobiology, Genetics, and Awareness Integration Theory in Addiction Recovery.
Journal: Psychology research and behavior management
Published: August 22, 2025
Harm Reduction Treatment for Substance Use.
Journal: Journal of psychiatric practice
Published: August 05, 2025
Pharmacogenomic-Based GWAS Meta-Analyses Coupled with Genetic and Epigenetic Liability Testing Connects Facial and Emotional Recognition Systems to Spectrum Disorders, Schizophrenia, Depression, and Anxiety.
Journal: Current pharmaceutical biotechnology
Published: August 03, 2025
Exploring dopamine as the master regulator of brain circuitry and mental health genome.
Journal: Gene & protein in disease
Published: August 01, 2025
Pharmacoepigenomics in Personalized Medicine: A Hypothesis-Generating Approach to Introduce CpG-PGx SNPs as New Candidates for a Systematic Insight into Genomic-Epigenomic-Phenomic-Pharmacogenomics (G-E-Ph-PGx) Axis.
Journal: Journal of personalized medicine
Published: July 16, 2025
PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and Misuse.
Journal: Current neuropharmacology
Published: March 21, 2025
Targeting pro-dopaminergic agonism to attenuate depression in patients displaying genetic/epigenetic predisposition to hypodopaminergia.
Journal: Frontiers in public health
Published: March 17, 2025
Last Updated: 09/26/2026